Literature DB >> 8196148

Sepsis therapy trials. Continued disappointment or reason for hope?

E Abraham, T A Raffin.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8196148     DOI： 10.1001/jama.271.23.1876

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

Review 1.  The cytokine response to critical illness.

Authors:  B A Foëx; M P Shelly
Journal:  J Accid Emerg Med       Date:  1996-05

2.  Balance of inflammatory cytokines related to severity and mortality of murine sepsis.

Authors:  K R Walley; N W Lukacs; T J Standiford; R M Strieter; S L Kunkel
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

Review 3.  Treatment of sepsis: past and future avenues.

Authors:  J D Baumgartner; T Calandra
Journal:  Drugs       Date:  1999-02       Impact factor: 9.546

Review 4.  Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock.

Authors:  Marissa M Alejandria; Mary Ann D Lansang; Leonila F Dans; Jacinto Blas Mantaring
Journal:  Cochrane Database Syst Rev       Date:  2013-09-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.